Clinical Chemistry Siemens Point of Care - Urinalysis
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Clinical Chemistry 46: 1260-1269, 2000;
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (22)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Triplett, D. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Triplett, D. A.
Related Collections
Right arrow Arnold O. Beckman Conference
Right arrow Hemostasis and Thrombosis
(Clinical Chemistry. 2000;46:1260-1269.)
© 2000 American Association for Clinical Chemistry, Inc.

Articles

Coagulation and Bleeding Disorders: Review and Update

Douglas A. Triplett1

1 Indiana University School of Medicine and Midwest Hemostasis and Thrombosis Laboratories, Ball Memorial Hospital, Muncie, IN 47303.

Hemostasis is initiated by injury to the vascular wall, leading to the deposition of platelets adhering to components of the subendothelium. Platelet adhesion requires the presence of von Willebrand factor and platelet receptors (IIb/IIIa and Ib/IX). Additional platelets are recruited to the site of injury by release of platelet granular contents, including ADP. The "platelet plug" is stabilized by interaction with fibrinogen. In this review, I consider laboratory tests used to evaluate coagulation, including prothrombin time, activated partial thromboplastin time, thrombin time, and platelet count. I discuss hereditary disorders of platelets and/or coagulation proteins that lead to clinical bleeding as well as acquired disorders, including disseminated intravascular coagulation and acquired circulating anticoagulants.




The following articles in journals at HighWire Press have cited this article:


Home page
 J Clin PharmacolHome page
M. D. Linnik, A. M. O'Rourke, and M. A. Crowther
Pharmacokinetics of High-Dose Abetimus Sodium in Normal Subjects With Specific Assessment of Effect on Coagulation
J. Clin. Pharmacol., August 1, 2008; 48(8): 909 - 918.
[Abstract] [Full Text] [PDF]

Home page
 PhysiologyHome page
E.-M. Wolber and W. Jelkmann
Thrombopoietin: The Novel Hepatic Hormone
Physiology, February 1, 2002; 17(1): 6 - 10.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Chem.Home page
G. Lippi and M. Franchini
Laboratory Screening for Abnormalities of Primary Hemostasis: What's Next?
Clin. Chem., November 1, 2001; 47(11): 2071 - 2071.
[Full Text] [PDF]

Home page
 Arch. Dis. Child.Home page
A Vora and M Makris
Personal practice: An approach to investigation of easy bruising
Arch. Dis. Child., June 1, 2001; 84(6): 488 - 491.
[Full Text]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2000 by the American Association for Clinical Chemistry.